DOBRINA, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 5.935
EU - Europa 2.420
AS - Asia 2.352
SA - Sud America 306
AF - Africa 101
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.126
Nazione #
US - Stati Uniti d'America 5.889
SG - Singapore 843
PL - Polonia 662
CN - Cina 640
UA - Ucraina 440
SE - Svezia 299
HK - Hong Kong 269
IT - Italia 251
BR - Brasile 247
VN - Vietnam 220
FI - Finlandia 151
FR - Francia 126
KR - Corea 123
GB - Regno Unito 107
DE - Germania 87
RU - Federazione Russa 87
TR - Turchia 87
MA - Marocco 74
BG - Bulgaria 68
IE - Irlanda 68
IN - India 39
JP - Giappone 19
MX - Messico 19
CH - Svizzera 18
AR - Argentina 17
CA - Canada 16
BD - Bangladesh 14
IQ - Iraq 14
SA - Arabia Saudita 14
BE - Belgio 13
EC - Ecuador 12
NL - Olanda 12
ZA - Sudafrica 11
ID - Indonesia 10
AU - Australia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PH - Filippine 7
PK - Pakistan 6
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
MY - Malesia 5
RO - Romania 5
ES - Italia 4
AT - Austria 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
KE - Kenya 3
LT - Lituania 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NP - Nepal 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MG - Madagascar 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 11.126
Città #
Woodbridge 716
Fairfield 603
Warsaw 591
Ashburn 524
Singapore 504
Ann Arbor 485
Houston 449
Jacksonville 385
Wilmington 334
Chandler 308
Hong Kong 265
Seattle 262
San Jose 241
Cambridge 218
Hefei 156
Princeton 132
Beijing 125
Seoul 121
Boardman 107
Chicago 87
Izmir 82
Santa Clara 78
Casablanca 69
Dublin 68
Sofia 68
Zgierz 66
Columbus 64
Ho Chi Minh City 63
Lauterbourg 59
Trieste 59
Hanoi 58
Milan 53
Los Angeles 52
Moscow 43
Buffalo 42
Dearborn 35
Frankfurt am Main 32
Dallas 31
The Dalles 29
San Diego 27
São Paulo 23
Falls Church 21
Munich 21
Düsseldorf 20
Jinan 18
Nanjing 17
Washington 16
London 15
Des Moines 14
Phoenix 14
Brussels 13
Guangzhou 13
Turku 13
Bern 12
Tokyo 12
Verona 12
New York 11
Shenyang 11
Tianjin 11
Helsinki 10
Norwalk 10
Council Bluffs 9
Jersey City 9
Kunming 9
Orem 9
Brooklyn 8
Da Nang 8
Denver 8
Hebei 8
Miano 8
Shanghai 8
Belo Horizonte 7
Montreal 7
Nanchang 7
Quito 7
Shenzhen 7
Atlanta 6
Auburn Hills 6
Dong Ket 6
Haiphong 6
Hangzhou 6
Johannesburg 6
Long Branch 6
Paris 6
Stockholm 6
Campinas 5
Fuzhou 5
Indiana 5
Nuremberg 5
Poplar 5
Portsmouth 5
Rio de Janeiro 5
Salvador 5
San Francisco 5
Secaucus 5
Tappahannock 5
Amsterdam 4
Brasília 4
Can Tho 4
Cardiff 4
Totale 8.242
Nome #
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 424
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. 413
Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. 392
Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. 239
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. 236
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction. 224
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase 216
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction 210
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 206
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 200
Disorders of neutrophil functions 198
Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. 197
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 196
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 196
Widespread myocardial inflammation and infarct-related artery patency. 191
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 190
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. 187
Complement-endothelial cell interactions: pathophysiological implications. 181
Effect of acylated flavonoids on neutrophil adherence to endothelial cells. 179
High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery. 178
Soluble interleukin-2 receptor: is there a role in ischaemic cardiomyopathy? 177
Apoptosis and post-infarction left ventricular remodeling. 174
Complement-endothelial cell interactions: pathophysiological implications. 173
Heterogeneity of macrophages as revealed by studies on their oxidative metabolism 170
Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. 169
Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation. 169
Inhibition of neutrophil adherence to vascular endothelial cells a new acylated flavonoid. 167
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 162
Prostacyclin in sepsis: a systematic review. 155
Cirrhotic cardiomyopathy. 155
Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy. 153
Effects of acylated flavonoids on neutrophil adherence to endothelial cells 152
New therapeutic approaches to liver fibrosis: a practicable route? 149
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. 149
Multiple receptors on human monocytes are involved in adhesion to cultured human endothelial cells. 149
CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (E-LAM) in vitro. 148
Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. 147
Iloprost: an adjunctive approach to chronic viral hepatitis treatment. 147
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 147
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention. 142
Metabolic properties of freshly isolated bovine endothelial cells. 135
Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. 135
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes 133
Complement-endothelial cell interaction: pathophysiological implications. 132
Prostacyclin in liver disease: a potential therapeutic option. 132
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications. 130
The respiratory burst and endothelial cells 129
Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis. 128
Phorbol ester causes down-regulation of CD11/CD18-independent neutrophil adherence to endothelium. 127
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 127
Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting. 118
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 117
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. 117
Enhanced portal flow velocity and volume following Iloprost treatment 117
Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor alpha from human monocytes. 116
Biological activity of a peptidoglycan extracted from Leptospira interrogans: in vitro studies. 116
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome. 112
null 108
Isolation of metabolically active endothelial cells in high yield from bovine cavernous bodies. A model for functional studies on freshly isolated microvascular endothelial cells. 108
[Mediastinal lymphangioma (with a report on 3 personal cases)]. 104
null 101
null 101
null 96
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. 93
Inhibition of netrophil adherence to vascular endothelial cells by a new acylated flavonoid. 88
Leptospira icterohemorrhagiae and leptospire peptidoglycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes 84
null 80
TUMOR NECROSIS FACTOR-ALPHA EXHIBITS GREATER PROINFLAMMATORY ACTIVITY THAN LYMPHOTOXIN IN VITRO. 76
Neutrophil-endothelial cell interaction:evidence for and mechanisms of bovine microvascular endothelial cells self protection from hydrogen peroxide-induced oxidative stress 74
null 67
null 64
High-Risk clinical increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery 63
null 61
Mechanisms of eosinophil adherence to cultured vascular endothelial cell. Eosinophils bind to the cytokine-induced endothelial ligand Vascular Cell Adhesion Molecule-1 via the Very Late Activation antigen-4 integrin receptor. 50
null 48
Totale 11.394
Categoria #
all - tutte 31.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 111 36 105
2021/2022737 30 41 26 51 12 61 24 32 83 70 81 226
2022/2023916 81 85 62 138 95 171 17 55 156 2 40 14
2023/2024532 38 31 27 27 62 67 99 97 5 11 29 39
2024/20251.004 18 16 54 83 169 89 89 59 103 108 92 124
2025/20262.707 146 193 244 375 247 282 438 104 288 390 0 0
Totale 11.394